Interest is growing in minimally invasive treatment options male lower urinary tract symptoms (LUTS), and preservation of all aspects of sexual function is increasingly important for patients. Here, the authors discuss initial experimental data on new minimally invasive procedures, such as the intraprostatic injection of novel agents, and the mechanical prostatic urethral lift device—Urolift®(Neotract, Inc., USA) for the treatment of LUTS caused by BPH.
- Giuseppe Magistro
- Christian G. Stief
- Christian Gratzke
